These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30060118)

  • 1. The FoxM1-ABCC4 axis mediates carboplatin resistance in human retinoblastoma Y-79 cells.
    Zhu X; Xue L; Yao Y; Wang K; Tan C; Zhuang M; Zhou F; Zhu L
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):914-920. PubMed ID: 30060118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2.
    Zhu X; Yu M; Wang K; Zou W; Zhu L
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):294-301. PubMed ID: 32152631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.
    Hou Y; Zhu Q; Li Z; Peng Y; Yu X; Yuan B; Liu Y; Liu Y; Yin L; Peng Y; Jiang Z; Li J; Xie B; Duan Y; Tan G; Gulina K; Gong Z; Sun L; Fan X; Li X
    Cell Death Dis; 2017 Mar; 8(3):e2659. PubMed ID: 28277541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
    Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
    Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1.
    Roh YG; Mun MH; Jeong MS; Kim WT; Lee SR; Chung JW; Kim SI; Kim TN; Nam JK; Leem SH
    BMB Rep; 2018 Feb; 51(2):98-103. PubMed ID: 29397866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
    Gu C; Jing X; Holman C; Sompallae R; Zhan F; Tricot G; Yang Y; Janz S
    BMC Cancer; 2018 Nov; 18(1):1152. PubMed ID: 30463534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corosolic acid induces cell cycle arrest and cell apoptosis in human retinoblastoma Y-79 cells via disruption of MELK-FoxM1 signaling.
    Wang K; Zhu X; Yao Y; Yang M; Zhou F; Zhu L
    Oncol Rep; 2018 Jun; 39(6):2777-2786. PubMed ID: 29620242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription.
    Hou Y; Dong Z; Zhong W; Yin L; Li X; Kuerban G; Huang H
    Biomed Res Int; 2022; 2022():3032590. PubMed ID: 35141332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
    Wang T; Liu Z; Shi F; Wang J
    Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.
    Wang K; Zhu X; Zhang K; Zhu L; Zhou F
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):804-9. PubMed ID: 27521795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
    Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
    Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
    Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression.
    Bi Z; Liu W; Ding R; Wu Y; Dou R; Zhang W; Yuan X; Liu X; Xiong L; Guo Z; Mao C
    Eur J Pharmacol; 2017 Feb; 796():175-189. PubMed ID: 28012972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy.
    Wang L; Zhai D; Tang L; Zhang H; Wang X; Ma N; Zhang X; Cheng M; Shen R
    Acta Biochim Biophys Sin (Shanghai); 2024 Jul; 56(9):1289-1299. PubMed ID: 39086352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
    Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.